Thousands flee Ebola-hit camp as DR Congo tests preventive drug
Thousands of people have fled an Ebola-hit camp in the Democratic Republic of Congo, raising concerns that the virus could spread further, Reuters reported.
Authorities in the country said more than 4,000 deaths have been recorded in the outbreak, according to Sky News.
DR Congo is also testing obeldesivir as a treatment intended to reduce the risk of Ebola infection after exposure. More than 250 people have enrolled in the prevention trial, according to reports citing PBS NewsHour. Several outlets identified the experimental drug as a Gilead product.
The trial and the movement of people from the affected camp come as authorities struggle to contain the virus.